Showing results (121-130 of 759) with videos related to
Sort By:
Pageof 76
The New England Journal of Medicine|January 27, 2006
Long-term outcome of renal transplantation from older donorsGiuseppe Remuzzi, Paolo Cravedi, Annalisa Perna, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2013
In kidney transplant patients, alemtuzumab but not basiliximab/low-dose rabbit anti-thymocyte globulin induces B cell depletion and regeneration, which associates with a high incidence of de novo donor-specific anti-HLA antibody developmentMarta Todeschini, Monica Cortinovis, Norberto Perico, et al.Diabetes Care|June 23, 2010
Effects of combined ezetimibe and simvastatin therapy as compared with simvastatin alone in patients with type 2 diabetes: a prospective randomized double-blind clinical trialPiero Ruggenenti, Dario Cattaneo, Stefano Rota, et al.Blood|July 20, 2002
von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndromeGiuseppe Remuzzi, Miriam Galbusera, Marina Noris, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 16, 2011
PPARγ2 P12A polymorphism and albuminuria in patients with type 2 diabetes: a meta-analysis of case-control studiesSalvatore De Cosmo, Sabrina Prudente, Olga Lamacchia, et al.Kidney International|February 12, 2004
In renal transplantation blood cyclosporine levels soon after surgery act as a major determinant of rejection: insights from the MY.S.S. trialNorberto Perico, Piero Ruggenenti, Eliana Gotti, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 9, 2005
Hemolytic uremic syndrome: a fatal outcome after kidney and liver transplantation performed to correct factor h gene mutationGiuseppe Remuzzi, Piero Ruggenenti, Michele Colledan, et al.Nephron|May 18, 2018
Safety of Iohexol Administration to Measure Glomerular Filtration Rate in Different Patient Populations: A 25-Year ExperienceFlavio Gaspari, Surabhi Thakar, Fabiola Carrara, et al.Clinical Kidney Journal|January 8, 2024
Mechanisms and treatment of obesity-related hypertension-Part 1: MechanismsAneliya Parvanova, Elia Reseghetti, Manuela Abbate, et al.BMJ Case Reports|August 27, 2014
Refractory focal segmental glomerulosclerosis in the adult: complete and sustained remissions of two episodes of nephrotic syndrome after a single dose of rituximabMaddalena Marasà, Paolo Cravedi, Barbara Ruggiero, et al.Pageof 76